EUVIMEDEUVIMED entdecken
Crossref

Obtusifolin mitigates CCl4-induced inflammation and liver fibrosis by modulating the ROCK2/ Cofilin-1 / NFκB pathway

Suriya Panneerselvam, Nidhi Sharma, Sai Balaji Andugulapati

European Journal of Pharmacology · 2026

DOI: 10.1016/j.ejphar.2025.178479 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmacology, 2026. Verfasst von Suriya Panneerselvam und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Hyderabad, 500 007, Telangana, India; Academy of Scientific and Innovati…. Hauptthemen laut MEDLINE: NF-kappa B, Liver Cirrhosis, rho-Associated Kinases, Anthraquinones. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver fibrosis is a progressive clinical condition characterised by an abnormal accumulation of extracellular matrix (ECM) components, which are predominantly generated by activated hepatic stellate cells (HSCs) and other fibrogenic cells. This process leads to liver stiffness, which can progress to cirrhosis, an irreversible condition, and ultimately result in liver failure. Obtusifolin (OBT), an anthraquinone derivative isolated from the seeds of Senna obtusifolia, is known for its potent anti-inflammatory and antioxidant properties. The present study evaluated the anti-fibrotic efficacy of OBT using in vitro models, including TGFβ-induced differentiation in HUCLS, HSC-LX2, and HHSECs, and an in vivo CCl4-induced liver fibrosis model in mice. The in vitro results demonstrated that OBT significantly suppressed the TGFβ-induced upregulation of fibrotic markers at both mRNA and protein levels. In vivo, findings showed that CCl4 treatment caused significant increases in serum liver function markers, inflammatory cell infiltration, collagen deposition, and septal fibrosis in liver tissues. In contrast, OBT treatment attenuated these pathological changes in a dose-dependent manner. Furthermore, assays on oxidative stress indicators revealed that OBT significantly reduced oxidative stress markers and enhanced antioxidant levels. Gene and protein expression analyses showed that OBT suppressed the CCl4-induced elevation of inflammatory cytokines, chemokines, and fibrotic markers compared to the CCl4 control group. Mechanistic studies demonstrated that CCl4 administration activated the ROCK2/p-cofilin-1/pNFκB signaling pathway, whereas OBT treatment significantly modulated these molecular pathways. OBT alleviates liver inflammation and fibrosis by inhibiting oxidative stress, collagen accumulation, and the ROCK2/NFκB pathway, highlighting its potential as a therapeutic candidate for liver fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BLiver Cirrhosisrho-Associated KinasesAnthraquinonesCofilin 1InflammationAnti-Inflammatory AgentsAnimalsMiceCarbon TetrachlorideSignal TransductionMaleHumansLiverOxidative StressCell LineHepatic Stellate CellsMice, Inbred C57BL

Stichwörter der Autor:innen

Cofilin-1InflammationLiver injury and NFκBMyofibroblastsROCK-2

Substanzen

NF-kappa Brho-Associated KinasesCarbon TetrachlorideAnthraquinonesCofilin 1Anti-Inflammatory AgentsRock2 protein, mouseROCK2 protein, human

Autor:innen und Institutionen

  • Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Hyderabad, 500 007, Telangana, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India.
  • Department of Applied Biology, CSIR-Indian Institute of Chemical Technology, Hyderabad, 500 007, Telangana, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India. Electronic address: bal…

Förderung

  • Council of Scientific and Industrial Research, India

Zitieren

APA

Panneerselvam, S., Sharma, N., & Andugulapati, S. B. (2026). Obtusifolin mitigates CCl4-induced inflammation and liver fibrosis by modulating the ROCK2/ Cofilin-1 / NFκB pathway. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2025.178479

Vancouver

Panneerselvam S, Sharma N, Andugulapati SB. Obtusifolin mitigates CCl4-induced inflammation and liver fibrosis by modulating the ROCK2/ Cofilin-1 / NFκB pathway. European Journal of Pharmacology. 2026. doi:10.1016/j.ejphar.2025.178479

BibTeX
@article{Panneerselvam2026,
  author = {Panneerselvam, Suriya and Sharma, Nidhi and Andugulapati, Sai Balaji},
  title = {Obtusifolin mitigates CCl4-induced inflammation and liver fibrosis by modulating the ROCK2/ Cofilin-1 / NFκB pathway},
  journal = {European Journal of Pharmacology},
  year = {2026},
  doi = {10.1016/j.ejphar.2025.178479}
}
Kostenlos starten →